Amedeo's Top 20

Amedeo Smart

Independent Medical Education

27 July 2015

Multidisciplinary Journal Club

  1. Edlin BR, Eckhardt BJ, Shu MA, Holmberg SD, et al.
    Towards a more accurate estimate of the prevalence of hepatitis C in the United States.
    Hepatology 2015.

  1. Henry ZH, Northup PG.
    Baclofen for the treatment of muscle cramps in patients with cirrhosis: A new alternative.
    Hepatology 2015.

  2. Boulvain M, Senat MV, Perrotin F, Winer N, et al.
    Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial.
    Lancet 2015;385:2600-5.

  3. Wohlbold TJ, Nachbagauer R, Margine I, Tan GS, et al.
    Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses.
    Vaccine 2015.

  4. Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, et al.
    alpha-Synuclein strains cause distinct synucleinopathies after local and systemic administration.
    Nature 2015;522:340-4.

  1. Cecconi M, Hofer C, Teboul JL, Pettila V, et al.
    Fluid challenges in intensive care: the FENICE study : A global inception cohort study.
    Intensive Care Med 2015.

  2. Santamaria JD, Duke GJ, Pilcher DV, Cooper DJ, et al.
    The timing of discharge from the intensive care unit and subsequent mortality. A prospective, multicenter study.
    Am J Respir Crit Care Med 2015;191:1033-9.

  3. Sands BE.
    Biomarkers of Inflammation in Inflammatory Bowel Disease.
    Gastroenterology 2015.

  4. Langerth A, Sandblom G, Karlson BM.
    Long-term risk for acute pancreatitis, cholangitis, and malignancy more than 15 years after endoscopic sphincterotomy: a population-based study.
    Endoscopy 2015.

  5. Shen JI, Montez-Rath ME, Lenihan CR, Turakhia MP, et al.
    Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Am J Kidney Dis 2015.

  1. Baragana B, Hallyburton I, Lee MC, Norcross NR, et al.
    A novel multiple-stage antimalarial agent that inhibits protein synthesis.
    Nature 2015;522:315-20.

  2. Robinson GW, Orr BA, Wu G, Gururangan S, et al.
    Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
    J Clin Oncol 2015.

  3. Alcolea D, Martinez-Lage P, Sanchez-Juan P, Olazaran J, et al.
    Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease.
    Neurology 2015.

  4. Scagliotti G, von Pawel J, Novello S, Ramlau R, et al.
    Phase III Multinational, Randomized, Double-Blind, Placebo-Controlled Study of Tivantinib (ARQ 197) Plus Erlotinib Versus Erlotinib Alone in Previously Treated Patients With Locally Advanced or Metastatic Nonsquamous Non-Small-Cell Lung %
    J Clin Oncol 2015.

  5. Li L, Streja E, Rhee CM, Mehrotra R, et al.
    Hypomagnesemia and Mortality in Incident Hemodialysis Patients.
    Am J Kidney Dis 2015.

  1. Perisinakis K, Seimenis I, Tzedakis A, Damilakis J, et al.
    Perfusion Scintigraphy Versus 256-Slice CT Angiography in Pregnant Patients Suspected of Pulmonary Embolism: Comparison of Radiation Risks.
    J Nucl Med 2014.

  2. Carhill AA, Litofsky DR, Ross DS, Jonklaas J, et al.
    Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987-2012.
    J Clin Endocrinol Metab 2015.

  3. Hill AM, McPhail SM, Waldron N, Etherton-Beer C, et al.
    Fall rates in hospital rehabilitation units after individualised patient and staff education programmes: a pragmatic, stepped-wedge, cluster-randomised controlled trial.
    Lancet 2015;385:2592-9.

  4. Daugirdas JT.
    Kt/V (and especially its modifications) remains a useful measure of hemodialysis dose.
    Kidney Int 2015.

  5. Richoz B, Hugli O, Dami F, Carron PN, et al.
    Acute stroke chameleons in a university hospital: Risk factors, circumstances, and outcomes.
    Neurology 2015.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016